help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kifor, O.
Right arrow Articles by Brown, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kifor, O.
Right arrow Articles by Brown, E. M.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 2 548-556
Copyright © 2004 by The Endocrine Society


Special Feature

Activating Antibodies to the Calcium-Sensing Receptor in Two Patients with Autoimmune Hypoparathyroidism

Olga Kifor, Aidan McElduff, Meryl S. LeBoff, Francis D. Moore, Jr., Robert Butters, Ping Gao, Thomas L. Cantor, Imre Kifor and Edward M. Brown

Division of Endocrinology (O.K., M.S.L., R.B., I.K., E.M.B.), Diabetes and Hypertension, and Membrane Biology Program, and Department of Surgery (F.D.M.), Brigham and Women’s Hospital, and Harvard Medical School (O.K., M.S.L., R.B., I.K., E.M.B., F.D.M.), Boston, Massachusetts 02115; Department of Endocrinology (A.M.), Royal North Shore Hospital, Sydney, Australia 2065; and Scantibodies Laboratories (P.G., T.L.C.), Santee, California 92071-2861

Address all correspondence and requests for reprints to: Edward M. Brown, M.D., Endocrine-Hypertension Division, Department of Medicine, Brigham and Women’s Hospital, 221 Longwood Avenue, Boston, Massachusetts 02115. E-mail: embrown{at}rics.bwh.harvard.edu.

Autoimmune hypoparathyroidism is thought to result from immune-mediated destruction of the parathyroid glands. We encountered two patients with hypoparathyroidism and other autoimmune conditions (Graves’ disease and Addison’s disease, respectively) in whom autoimmune destruction of the parathyroid glands had not taken place. In the first, a histologically normal parathyroid gland was observed at the time of subtotal thyroidectomy; and in the second, the hypoparathyroidism remitted spontaneously. Both patients had antibodies that reacted with the cell surface of bovine parathyroid cells and human embryonic kidney (HEK293) cells transfected with the extracellular calcium-sensing receptor (CaR) but not with nontransfected HEK293 cells. The antibodies also reacted with the same bands on Western analysis of extracts of bovine parathyroid tissue and CaR-transfected HEK293 cells that were identified by an authentic, polyclonal, anti-CaR antiserum and reacted with several peptides with sequences from the CaR’s extracellular domain. These anti-CaR antibodies activated the receptor based on their ability to increase inositol phosphate accumulation, activate MAPK, and inhibit PTH secretion. These results, therefore, demonstrate that patients with the biochemical findings of primary hypoparathyroidism can harbor activating antibodies to the CaR, which, in the two cases studied here, did not produce irreversible destruction of the parathyroid glands.

This work was supported by the NIH (DK41415, DK48330, and DK52005) and The St. Giles Foundation.

Abbreviations: APS, Autoimmune polyendocrinopathy syndrome; Ca2+i, cytosolic calcium concentration; Ca2+o, extracellular calcium; CaR, calcium-sensing receptor; GF, glomerular filtrate; GFR, glomerular filtration rate; nl., normal; pERK, phospho-ERK; SDS, sodium dodecyl sulfate.




This article has been cited by other articles:


Home page
NEJMHome page
D. Shoback
Hypoparathyroidism
N. Engl. J. Med., July 24, 2008; 359(4): 391 - 403.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. G. Gavalas, E. H. Kemp, K. J. E. Krohn, E. M. Brown, P. F. Watson, and A. P. Weetman
The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2107 - 2114.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. Huang, A. Sindic, C. E. Hill, K. M. Hujer, K. W. Chan, M. Sassen, Z. Wu, Y. Kurachi, S. Nielsen, M. F. Romero, et al.
Interaction of the Ca2+-sensing receptor with the inwardly rectifying potassium channels Kir4.1 and Kir4.2 results in inhibition of channel function
Am J Physiol Renal Physiol, March 1, 2007; 292(3): F1073 - F1081.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Mayer, C. Ploix, J. Orgiazzi, A. Desbos, A. Moreira, H. Vidal, J.-C. Monier, J. Bienvenu, and N. Fabien
Calcium-Sensing Receptor Autoantibodies Are Relevant Markers of Acquired Hypoparathyroidism
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4484 - 4488.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. F. Stewart
Translational Implications of the Parathyroid Calcium Receptor
N. Engl. J. Med., July 22, 2004; 351(4): 324 - 326.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. H. S. Pearce and N. J. Leech
Toward Precise Forecasting of Autoimmune Endocrinopathy
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 544 - 547.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society